Long-term use of omalizumab in patients with allergic bronchopulmonary aspergillosis: a tertiary-level care center experience.

Mehmet Erdem Cakmak Nida Öztop Osman Ozan Yeğit

Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2024)

Long-term omalizumab use in patients with ABPA seems to be an effective treatment for improving pulmonary function and reducing asthma exacerbations and hospitalizations.

Keyphrases

chronic obstructive pulmonary disease
healthcare
allergic rhinitis
palliative care
smoking cessation